@davybabyk
What do you think is meant b "Imugene and Celularity Announce an Exclusive Strategic Partnership to Develop a Novel Oncolytic Virus - Allogeneic CAR T-Cell Immunotherapy Combination for the Treatment of Solid Tumors"
Does this imply IMU won't partner with any other CAR-T companies with CF33-CD19 for solid tumours?
Thanks in advance.
GLTAHs
Ann: Research partnership with Celularity for solid tumors, page-86
-
- There are more pages in this discussion • 93 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $373.3M | |||
| Open | High | Low | Value | Volume |
| 5.1¢ | 5.2¢ | 4.9¢ | $1.384M | 27.31M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1302118 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 528865 | 4 |
View Market Depth
| Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |